MorphoSys AG

06/25/2021 | Press release | Distributed by Public on 06/25/2021 05:48

MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large[...]